NCT00690794 - Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

726

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Open-angle GlaucomaOcular Hypertension

Interventions

DRUG

Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)

Ophthalmic solution for the treatment of open-angle glaucoma or ocular hypertension, one drop a day, dosed topically for 90 days. Referred to as travoprost.

DRUG

Latanoprost ophthalmic solution 0.005% (XALATAN®)

Ophthalmic solution for the treatment of open-angle glaucoma or ocular hypertension, one drop a day, dosed topically for 90 days. Referred to as latanprost.